FDA Inspection
AlloSourceAlloSource – FDA Inspection, Mar 12, 2012
Record Details
This FDA Inspection record concerns AlloSource, with an inspection on March 12, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- AlloSource
- Inspection Date
- March 12, 2012
- Product Type
- Biologics
View Company Profile
ID · 95c52244-2c9a-4fb0-86e9-6e077d808b28
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 771277
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.260(a)Contamination, mix ups, improper release
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AlloSource
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 30, 2022 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 22, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 5, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 28, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for AlloSource
- FDA Inspection 1180198 - 2022-08-30
- FDA Inspection 1012394 - 2017-05-22
- FDA Inspection 916763 - 2015-03-05
- FDA Inspection 659873 - 2010-04-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.